Castle Biosciences Inc. (CSTL) Reports In-Line Q1 EPS

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q1 EPS of ($0.49), in-line with the analyst estimate of ($0.49). Revenue for the quarter came in at $83.7 million versus the consensus estimate of $77.46 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c